PATENT CLAIM ANALYSIS

Application Number: 15744537
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "182000"]

Abstract:
[Problem] To provide a therapeutic agent for estrogen-dependent gynecological diseases such as endometriosis, uterine fibroids, and uterus adenomyosis. [Solution] To use an estrogen receptor α-inhibiting β partial agonist represented by the formula (a), a pharmaceutically-acceptable salt thereof, or a hydrate of either of the afore-mentioned, as an active ingredient.

Claim (Index 3):
The gynecological disease therapeutic agent according to  claim 2 , wherein the gynecological disease comprises endometriosis, uterine fibroids, and/or uterus adenomyosis.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.31915
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10495708', '12160460', '14386726', '10384775', '14781180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7510791698140404
- 35 USC 102 Novelty (BERT): 0.4877875570452789
- Combined Prediction Score: 0.7247500085371643
- Mean Citation Score: 160.06669399999996
- Max Citation Score: 166.36595
- Similarity Product: 111.1820921580017

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test